Skip to main content
Medical information Clinical review pending

Genetic Testing

C7 Gene C7 Deficiency Genetic Test

The C7 Gene C7 Deficiency NGS Genetic DNA Test identifies genetic mutations in the C7 gene associated with C7 deficiency, a condition linked to certain immune and skin disorders. This test is important for individuals with a family history or symptoms suggestive of related conditions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
A blood sample is required for this test. Confirm with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is typically required for this blood test. However, confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the C7 Gene C7 Deficiency Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of C7 deficiency or related disorders.
  • ✓Recurrent infections, especially Neisseria infections.
  • ✓Diagnosis of autoimmune conditions potentially linked to complement deficiencies.
  • ✓Genetic counseling for hereditary health risks.
  • ✓Unexplained skin lesions or immunological issues.
  • ✓Pre-surgical screening in certain cases.
02

In plain language

What this test helps you understand

This test helps identify individuals with genetic mutations in the C7 gene, which can lead to C7 deficiency. C7 deficiency is associated with an increased susceptibility to certain infections, particularly Neisseria species, and can also be linked to autoimmune conditions. Identifying carriers or affected individuals allows for appropriate medical management and preventative measures.
The C7 Gene C7 Deficiency NGS Genetic DNA Test uses advanced Next Generation Sequencing (NGS) technology to examine the C7 gene for variations. This gene is important for immune function and skin health. Identifying mutations in this gene can help assess the risk of developing C7 deficiency and related health issues. Understanding your genetic predisposition is key for proactive health management, particularly if there is a family history of similar conditions. This test provides crucial information for diagnosis, treatment planning, and genetic counseling.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for this blood test. However, confirm with the laboratory before booking.
SampleA blood sample is required for this test. Confirm with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) is used to analyze the C7 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific regions of the C7 gene. It may not detect all possible mutations, such as deep intronic mutations or large deletions/duplications, unless specifically requested. Results should be interpreted in the context of clinical findings and family history.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

C7 deficiency is a rare genetic disorder where the body lacks sufficient C7 protein, a component of the immune system's complement cascade. This can increase susceptibility to certain infections and potentially autoimmune diseases.
Individuals with a family history of C7 deficiency or related complement disorders are at higher risk. Those experiencing recurrent infections, particularly with Neisseria bacteria, may also be candidates for testing.
The test involves analyzing a blood sample using Next Generation Sequencing (NGS) to look for specific genetic changes (mutations) in the C7 gene.
Results should be interpreted by a qualified healthcare professional, such as a doctor or genetic counselor, who can explain the findings in the context of your medical history and family background.
Your doctor will discuss the results with you and recommend appropriate follow-up actions, which may include further testing, medical management, or genetic counseling for family members.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp